1Department of Pathology, Jawahar Lal Nehru Medical College, Aligarh, India
2Department of Oral Pathology and Microbiology, Sardar Patel Post Graduate Institute of Dental & Medical Sciences, Lucknow, India
3Department of Community Medicine, Jawahar Lal Nehru Medical College, AMU, Aligarh, India
4Department of Oral Pathology and Microbiology, King George Medical University, Lucknow, India
© 2018 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Type of lesion | No. of cases |
α-SMA intensity score (%) |
|||
---|---|---|---|---|---|
0 | 1+ (mild) | 2+ (moderate) | 3+ (intense) | ||
WDSCC | 29 | 4 (13.8) | 17 (58.6) | 8 (27.6) | 0 |
MDSCC | 25 | 0 | 7 (28) | 13 (52) | 5 (20) |
PDSCC | 11 | 0 | 0 | 3 (27.3) | 8 (72.7) |
Type of lesion | No. of cases | Negative staining | Focal pattern | Spindle pattern | Network pattern |
---|---|---|---|---|---|
WDSCC | 29 | 4 (13.8) | 19 (65.5) | 6 (20.7) | 0 |
MDSCC | 25 | 0 | 3 (12) | 8 (32) | 14 (56) |
PDSCC | 11 | 0 | 0 | 2 (18.2) | 9 (81.8) |
Group | No. | Mean ± SD | Minimum–Maximum |
---|---|---|---|
WDSCC | 29 | 2.9 ± 1.1 | 1.0–5.3 |
MDSCC | 25 | 1.9 ± 0.5 | 1.0–3.4 |
PDSCC | 11 | 1.3 ± 0.4 | 1.0–2.2 |
Normal mucosa | 11 | 2.7 ± 1.0 | 1.1–4.2 |
ANOVA test results: F(3,72) = 13.423, p < .001. Significant at p < .01.
Post-hoc Tukey’s honest significant difference testing reveals significant differences between WDSCC and MDSCC (p < .001); WDSCC and PDSCC (p < .001); MDSCC and normal (p = .041); and; PDSCC and normal (p = .002).
SD, standard deviation; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Group |
Fibre orientation |
Total | |
---|---|---|---|
Haphazard | Parallel | ||
WDSCC | 13 (44.8) | 16 (55.2) | 29 (100) |
MDSCC | 19 (76) | 6 (24) | 25 (100) |
PDSCC | 11 (100) | 0 (0) | 11 (100) |
Total | 43 (66.2) | 22 (33.82) | 65 (100) |
Group |
Fibre arrangement |
Total | |
---|---|---|---|
Dense | Loose | ||
WDSCC | 19 (65.5) | 10 (34.5) | 29 (100) |
MDSCC | 10 (40) | 15 (58.8) | 25 (100) |
PDSCC | 0 | 11 (100) | 11 (100) |
Total | 29 (44.6) | 36 (55.4) | 65 (100) |
Group | No. | Mean ± SD (%) | Minimum–Maximum |
---|---|---|---|
WDSCC | 29 | 25.1 ± 5.5 | 17.7–37.0 |
MDSCC | 25 | 18.9 ± 3.7 | 11.5–24.1 |
PDSCC | 11 | 10.6 ± 3.0 | 7.0–16.3 |
Normal mucosa | 11 | 31.5 ± 3.5 | 27.4–36.2 |
ANOVA test results. F(3,72) = 51.2, p < .001. Significant at p < .05.
Post-hoc Tukey’s honest significant difference (HSD) testing reveals significant differences between all of the groups with each other (p < .001).
SD, standard deviation; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Values are presented as number (%).
Fisher’s exact test, p < .001. Significant at p <. 01.
OR, orange red; YO, yellowish orange; GY, greenish yellow; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Type of lesion | No. of cases | α-SMA intensity score (%) |
|||
---|---|---|---|---|---|
0 | 1+ (mild) | 2+ (moderate) | 3+ (intense) | ||
WDSCC | 29 | 4 (13.8) | 17 (58.6) | 8 (27.6) | 0 |
MDSCC | 25 | 0 | 7 (28) | 13 (52) | 5 (20) |
PDSCC | 11 | 0 | 0 | 3 (27.3) | 8 (72.7) |
Type of lesion | No. of cases | Negative staining | Focal pattern | Spindle pattern | Network pattern |
---|---|---|---|---|---|
WDSCC | 29 | 4 (13.8) | 19 (65.5) | 6 (20.7) | 0 |
MDSCC | 25 | 0 | 3 (12) | 8 (32) | 14 (56) |
PDSCC | 11 | 0 | 0 | 2 (18.2) | 9 (81.8) |
Group | No. | Mean ± SD | Minimum–Maximum |
---|---|---|---|
WDSCC | 29 | 2.9 ± 1.1 | 1.0–5.3 |
MDSCC | 25 | 1.9 ± 0.5 | 1.0–3.4 |
PDSCC | 11 | 1.3 ± 0.4 | 1.0–2.2 |
Normal mucosa | 11 | 2.7 ± 1.0 | 1.1–4.2 |
Group | Fibre orientation |
Total | |
---|---|---|---|
Haphazard | Parallel | ||
WDSCC | 13 (44.8) | 16 (55.2) | 29 (100) |
MDSCC | 19 (76) | 6 (24) | 25 (100) |
PDSCC | 11 (100) | 0 (0) | 11 (100) |
Total | 43 (66.2) | 22 (33.82) | 65 (100) |
Group | Fibre arrangement |
Total | |
---|---|---|---|
Dense | Loose | ||
WDSCC | 19 (65.5) | 10 (34.5) | 29 (100) |
MDSCC | 10 (40) | 15 (58.8) | 25 (100) |
PDSCC | 0 | 11 (100) | 11 (100) |
Total | 29 (44.6) | 36 (55.4) | 65 (100) |
Group | No. | Mean ± SD (%) | Minimum–Maximum |
---|---|---|---|
WDSCC | 29 | 25.1 ± 5.5 | 17.7–37.0 |
MDSCC | 25 | 18.9 ± 3.7 | 11.5–24.1 |
PDSCC | 11 | 10.6 ± 3.0 | 7.0–16.3 |
Normal mucosa | 11 | 31.5 ± 3.5 | 27.4–36.2 |
Group | Hue |
Total | ||
---|---|---|---|---|
OR | YO | GY | ||
Normal mucosa | 6 (54.6) | 4 (36.4) | 1 (9.1) | 11 (100) |
WDSCC | 18 (62) | 8 (27.5) | 3 (10.3) | 29 (100) |
MDSCC | 9 (35.3) | 13 (52) | 3 (12) | 25 (100) |
PDSCC | 0 (0) | 3 (27.3) | 8 (72.7) | 11 (100) |
Total | 33 (43.4) | 28 (36.8) | 15 (19.7) | 76 (100) |
Group | Birefringence |
Total | |
---|---|---|---|
Strong | Weak | ||
Normal mucosa | 10 (90.9) | 1 (9.1) | 11 (100) |
WDSCC | 26 (89.6) | 3 (10.3) | 29 (100) |
MDSCC | 19 (76) | 6 (24.0) | 25 (100) |
PDSCC | 3 (27.3) | 8 (72.7) | 11 (100) |
Total | 60 (81.1) | 14 (18.9) | 76 (100) |
Values are presented as number (%). Fisher exact test p < .001. α-SMA, α-smooth muscle actin; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Values are presented as number (%). Fisher exact test p < .001. α-SMA, α-smooth muscle actin; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
ANOVA test results: F(3,72) = 13.423, p < .001. Significant at p < .01. SD, standard deviation; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Values are presented as number (%). Chi-square = 12.6, df = 2, p = .002. Significant at p < .05. WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Values are presented as number (%). Chi-square = 14.2, df = 2, p = .001. Significant at p < .05. WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
ANOVA test results. F(3,72) = 51.2, p < .001. Significant at p < .05. SD, standard deviation; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Values are presented as number (%). Fisher’s exact test, p < .001. Significant at p <. 01. OR, orange red; YO, yellowish orange; GY, greenish yellow; WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.
Values are presented as number (%). Chi-square = 19.2, df = 3, p < .001. Significant at p < .01. WDSCC, well differentiated squamous cell carcinoma; MDSCC, moderately differentiated squamous cell carcinoma; PDSCC, poorly differentiated squamous cell carcinoma.